Becker's Clinical Quality & Infection Control

January/February 2021 IC_CQ

Issue link: https://beckershealthcare.uberflip.com/i/1337263

Contents of this Issue

Navigation

Page 47 of 47

1. References list: https://www.nozin.com/clinical-outcomes. Outcomes reported by actual users. Your results may vary. Nozin® Nasal Sanitizer® antiseptic is for nasal decolonization. ©2020 Global Life Technologies Corp. All rights reserved. Made in USA. Nozin®, Nasal Sanitizer®, Popswab®, NOVA SM and Nozaseptin® are trademarks of Global Life Technologies Corp. Nozin® Nasal Sanitizer® antiseptic is an OTC topical drug. No claim is made that it has an effect on any specific disease. Patent nos.: nozin.com/patents. Proven MRSA / MSSA colonization risk mitigation Contact Nozin to learn more about NOVA SM programs. Visit: nozin.com/nova Call: 877-669-4648 NOVA SM programs are working nationwide. The NOVA SM approach is clinically proven to help reduce MRSA infection risks up to 100%, decrease contact precautions 42%, increase patient as well as staff satisfaction and save up to $1.4 million in a year. 1 Welcome to NOVA SM by Nozin. Nozin, leaders in developing and implementing MRSA / MSSA risk mitigation programs introduces NOVA SM . A proprietary suite of tools and services, NOVA SM programs are guided by experienced consultants and proven to reduce infection risks while improving patient care. #1 Brand in Daily Nasal Decolonization NOVA SM is powered by Presents

Articles in this issue

Links on this page

view archives of Becker's Clinical Quality & Infection Control - January/February 2021 IC_CQ